PIK3CA and PIK3CB Inhibition Produce Synthetic Lethality when Combined with Estrogen Deprivation in Estrogen Receptor-Positive Breast Cancer
Chanpheng Phommaly(Washington University in St. Louis), Matthew J. Ellis(University of California, Davis), Lin Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Jeremy Hoog(Washington University in St. Louis), Anthony J. Saporita, Jingqin Luo(Washington University in St. Louis), Yu Tao(Harbin Institute of Technology), Joel S. Parker(University of North Carolina at Chapel Hill), Charles M. Perou(University of North Carolina at Chapel Hill), Sherri R. Davies(Washington University in St. Louis), David G. Huntsman(BC Cancer Agency), Melinda A. Miller(University of North Carolina at Chapel Hill), Robert J. Crowder(University of Rochester), Jacqueline Snider(Washington University in St. Louis), Jason D. Weber(Washington University in St. Louis), John A. Olson(Vanderbilt University), Mark A. Watson(Washington University in St. Louis)
Cited by 11
Related Papers
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
The Immune Landscape of Cancer
|Immunity|2018|6.3k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
|Clinical Cancer Research|2004|2.7k